Jane Street’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-65,878
Closed -$643K 11689
2025
Q4
$758K Sell
65,878
-14,088
-18% -$218K ﹤0.01% 6754
2025
Q3
$1.94M Buy
79,966
+63,723
+392% +$1.06M ﹤0.01% 4997
2025
Q2
$267K Buy
16,243
+11,769
+263% +$203K ﹤0.01% 8062
2025
Q1
$81.4K Sell
4,474
-2,410
-35% -$68.8K ﹤0.01% 8885
2024
Q4
$255K Buy
6,884
+2,339
+51% +$89.5K ﹤0.01% 7995
2024
Q3
$145K Sell
4,545
-4,864
-52% -$270K ﹤0.01% 8833
2024
Q2
$773K Sell
9,409
-29,306
-76% -$3.17M ﹤0.01% 6269
2024
Q1
$5.61M Buy
38,715
+27,984
+261% +$2.36M ﹤0.01% 2464
2023
Q4
$988K Buy
10,731
+2,046
+24% +$208K ﹤0.01% 5584
2023
Q3
$1.43M Buy
8,685
+3,861
+80% +$502K ﹤0.01% 4600
2023
Q2
$305K Buy
4,824
+182
+4% +$11K ﹤0.01% 7097
2023
Q1
$158K Sell
4,642
-779
-14% -$40.7K ﹤0.01% 7984
2022
Q4
$313K Buy
+5,421
New +$335K ﹤0.01% 6939
2022
Q3
Sell
-1,348
Closed -$192K 9748
2022
Q2
$300K Buy
1,348
+274
+26% +$91.8K ﹤0.01% 7605
2022
Q1
$590K Sell
1,074
-295
-22% -$178K ﹤0.01% 7158
2021
Q4
$905K Sell
1,369
-196
-13% -$150K ﹤0.01% 6107
2021
Q3
$1.31M Buy
1,565
+1,250
+397% +$1.27M ﹤0.01% 5352
2021
Q2
$399K Sell
315
-2,366
-88% -$2.67M ﹤0.01% 7665
2021
Q1
$2.94M Buy
2,681
+1,798
+204% +$2.37M ﹤0.01% 3284
2020
Q4
$1.26M Sell
883
-938
-52% -$1M ﹤0.01% 4283
2020
Q3
$1.28M Buy
1,821
+564
+45% +$410K ﹤0.01% 3682
2020
Q2
$880K Buy
1,257
+679
+117% +$392K ﹤0.01% 4250
2020
Q1
$201K Buy
+578
New +$409K ﹤0.01% 4644
2019
Q4
Sell
-1,138
Closed -$381K 5089
2019
Q3
$381K Buy
+1,138
New +$365K ﹤0.01% 3879

Other funds holding CDLX

Jane Street's CDLX Position: Q1 2026 in Review

Jane Street sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 65,878 shares — an estimated $643K sold.

Jane Street first reported a position in CDLX in Q3 2019 and held it in 24 quarters. The position peaked at $5.61M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Jane Street reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 65,878 Cardlytics shares in Q1 2026, an estimated $643K.
  • Jane Street first reported a position in Cardlytics in Q3 2019 and held it in 24 quarters.
  • Jane Street's Cardlytics position peaked at $5.61M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.